Compare ORA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORA | HAE |
|---|---|---|
| Founded | 1965 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 2004 | 1996 |
| Metric | ORA | HAE |
|---|---|---|
| Price | $86.81 | $118.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $126.33 | $124.50 |
| AVG Volume (30 Days) | ★ 704.1K | 607.7K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.14 | 0.72 |
| Revenue | $719,267,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $19.26 | $6.21 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ $77.04 | $162.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $85.77 | $48.98 |
| 52 Week High | $146.39 | $123.77 |
| Indicator | ORA | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 64.22 |
| Support Level | N/A | $100.92 |
| Resistance Level | $93.96 | $123.77 |
| Average True Range (ATR) | 2.39 | 3.68 |
| MACD | 0.19 | -0.20 |
| Stochastic Oscillator | 14.53 | 77.24 |
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.